Interface Biosciences
3 known investors
Interface Bio develops immunotherapies targeting complex inflammatory diseases by combining biological evolution, metabolomics, and machine learning to discover natural-derived therapeutic products.
AI & Machine LearningBiotechDeep TechMedical Devices
Founders & leadership
SP
Stanford PhD (Co-founder)Co-founder